Pharmacies across Oklahoma say they are losing hundreds of thousands of dollars because they say a company, CVS Caremark, is supposed to reimburse them for prescriptions and isn't holding up their end ...

TD Cowen analyst Ryan Langston maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $391.00. The company’s ...

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

Oklahoma's attorney general has accused CVS's Caremark pharmacy benefit manager unit of under-reimbursing pharmacies for ...

Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...

Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

Witty's comments came during the company's first earnings call since the killing of Brian Thompson, the CEO of the company's ...